AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Earnings per share

Nissui Pharmaceutical Co., Ltd.【JP:E00971】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 202251.2+76.86%
Mar 31, 202129+61.28%
Mar 31, 202018-48.79%
Mar 31, 201935.1-33.24%
Mar 31, 201852.5-38.21%
Mar 31, 201785-6.77%
Mar 31, 201691.1-17.39%
Mar 31, 2015110.3+7.17%
Mar 31, 2014103+3.31%
Mar 31, 201399.7+38.13%
Mar 31, 201272.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)